Page 103 - Sitomegalovirüs Tanı, Tedavi Uzlaşı Raporu

138. Bartlet JG. Overview of primary prevention of opportunistic infections in HIV-infected
patients. Section Editor: Hirsch MS, Deputy Editor: Mitty J. UpToDate.
http://www.uptodate.com/contents/overview-of-primary-prevention-of-opportunistic-
infections-in-hiv-infected-patients (09.02.2019)
139. Hoffman C. Opportunistic infections. HIV 2015/2016. Edited by: Hoffman C and
Rockstroh JK. https://hivbook.files.wordpress.com/2016/04/hiv-2015-16-complete.pdf
140. Capella MJ, Foster CS. Herpesviruses. In: Diagnosis & Treatment of Uveitis. 2nd
Edition. Foster CS & Vitale AT eds. New Delhi, Jaypee-Highlights Medical Publishers
Ltd. 2013, 543-568.
141. Touhami S, Qu L, Angi M, Bojanova M, Touitou V, Lehoang P, Rozenberg F, Bodaghi
B. Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term
Outcomes in a French Series. Am J Ophthalmol. 2018;194:134-142.
142. Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK. Cytomegalovirus retinitis after
fluocinolone acetonide (Retisert) implant. Am J Ophthalmol. 2007;143:334-5.
143. Tugal-Tutkun I, Araz B, Cagatay A. CMV retinitis after intravitreal triamcinolone
acetonide injection in a patient with Behçet's uveitis. Int Ophthalmol. 2010;30:591-3.
144. Port AD, Orlin A, Kiss S, Patel S, D'Amico DJ, Gupta MP. Cytomegalovirus Retinitis:
A Review. J Ocul Pharmacol Ther. 2017;33(4):224-34.
145. Miyazaki D, Shimizu D, Shimizu Y, Inoue Y, Inoue T, Higaki S, Ueta M, Sugita S,
Real-time PCR for ocular cytomegalovirus infection study group. Diagnostic efficacy
of real-time PCR for ocular cytomegalovirus infections. Graefe's Archive for Clinical
and Experimental Ophthalmology. 2018:256;2413-20.
146. Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD. Treatment of
cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir
Implant Study Group. N Engl J Med. 1997;337:83-90.
147. Sloan DJ, Taegtmeyer M, Pearce IA, Hart IJ, Miller AR, Beeching NJ.
Cytomegalovirus retinitis in the absence of HIV or immunosuppression. Eur J
Ophthalmol. 2008;18(5):813-5.
148. Markomichelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G.
Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy.
Ophthalmology. 2002;109:879-82.
149. Accorinti M, Gilardi M, Pirraglia MP, Amorelli GP, Nardella C& Abicca I, Pesci FR
Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients.
Graefes Arch Clin Exp Ophthalmol. 2014;252:1817-1824.
150. Zandi S, Bodaghi B, Garweg JG. Review for Disease of the Year: Treatment of Viral
Anterior Uveitis: A Perspective. Ocul Immunol Inflamm. 2018;26(7):1135-1142.
151. Lv Y, Han F, Jia Y, Wan Z, Gong L, Liu H, Liuet L. Is cytomegalovirus infection
related to inflammatory bowel disease, especially steroid-resistant inflammatory
bowel disease? A meta-analysis. Infection and Drug Resistance. 2017;10:511-19.
152. Siegmund B. Cytomegalovirus infection associated with inflammatory bowel disease.
Lancet Gastroenterol Hepatol. 2017;2:369-76.
153. Ramos GP, Papadakis KA. Mechanism of disease: Inflammatory bowel diseases.
Mayo Clin Proc. 2019;94(1):155-165.
154. Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: Role in
diagnosis, management, and treatment. World J Gastroenterol. 2018;24(35):4014-20.
155. Ateya R, Neurath MF. Current and Future Targets for Mucosal Healing in
Inflammatory Bowel Disease. Visc Med. 2017;33(1):82-8.

100